Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine M Shea

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Journal of Clinical Pharmacology|April 1, 2015
Population pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese and nonobese patientsEun Kyoung Chung, S Christian Cheatham, Megan R Fleming, et al.
International Journal of Antimicrobial Agents|September 4, 2009
Steady-state pharmacokinetics and pharmacodynamics of piperacillin/tazobactam administered by prolonged infusion in hospitalised patientsKatherine M Shea, S Christian Cheatham, Matthew F Wack, et al.
The Annals of Pharmacotherapy|October 8, 2009
Comparative pharmacodynamics of intermittent and prolonged infusions of piperacillin/tazobactam using Monte Carlo simulations and steady-state pharmacokinetic data from hospitalized patientsKatherine M Shea, S Christian Cheatham, David W Smith, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|January 17, 2025
Rise of the beta-lactams: a retrospective, comparative cohort of oral beta-lactam antibiotics as step-down therapy for hospitalized adults with acute pyelonephritisAthena L V Hobbs, Vagish S Hemmige, Katie L Reel, et al.
The Journal of Antimicrobial Chemotherapy|March 18, 2016
Are first-generation cephalosporins obsolete? A retrospective, non-inferiority, cohort study comparing empirical therapy with cefazolin versus ceftriaxone for acute pyelonephritis in hospitalized patientsAthena L V Hobbs, Katherine M Shea, Mitchell J Daley, et al.
Cureus|February 23, 2017
Correction: Hydration Status as a Predictor of High-altitude Mountaineering PerformanceEric Ladd, Katherine M Shea, Patrick Bagley, et al.
Cureus|January 14, 2017
Hydration Status as a Predictor of High-altitude Mountaineering PerformanceEric Ladd, Katherine M Shea, Patrick Bagley, et al.
Journal of Clinical Pharmacology|October 15, 2013
Steady-state pharmacokinetics and pharmacodynamics of meropenem in morbidly obese patients hospitalized in an intensive care unitS Christian Cheatham, Megan R Fleming, Daniel P Healy, et al.
Journal of Pharmacy Practice|August 30, 2017
Significant Publications on Infectious Diseases Pharmacotherapy in 2016Gary Fong, Erik W Skoglund, Kady Phe, et al.
Antimicrobial Agents and Chemotherapy|March 29, 2017
Effect of a Health Care System Respiratory Fluoroquinolone Restriction Program To Alter Utilization and Impact Rates of Clostridium difficile InfectionKatherine M Shea, Athena L V Hobbs, Theresa C Jaso, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of Clinical Pharmacology|April 1, 2015
Population pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese and nonobese patientsEun Kyoung Chung, S Christian Cheatham, Megan R Fleming, et al.
International Journal of Antimicrobial Agents|September 4, 2009
Steady-state pharmacokinetics and pharmacodynamics of piperacillin/tazobactam administered by prolonged infusion in hospitalised patientsKatherine M Shea, S Christian Cheatham, Matthew F Wack, et al.
The Annals of Pharmacotherapy|October 8, 2009
Comparative pharmacodynamics of intermittent and prolonged infusions of piperacillin/tazobactam using Monte Carlo simulations and steady-state pharmacokinetic data from hospitalized patientsKatherine M Shea, S Christian Cheatham, David W Smith, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|January 17, 2025
Rise of the beta-lactams: a retrospective, comparative cohort of oral beta-lactam antibiotics as step-down therapy for hospitalized adults with acute pyelonephritisAthena L V Hobbs, Vagish S Hemmige, Katie L Reel, et al.
The Journal of Antimicrobial Chemotherapy|March 18, 2016
Are first-generation cephalosporins obsolete? A retrospective, non-inferiority, cohort study comparing empirical therapy with cefazolin versus ceftriaxone for acute pyelonephritis in hospitalized patientsAthena L V Hobbs, Katherine M Shea, Mitchell J Daley, et al.
Cureus|February 23, 2017
Correction: Hydration Status as a Predictor of High-altitude Mountaineering PerformanceEric Ladd, Katherine M Shea, Patrick Bagley, et al.
Cureus|January 14, 2017
Hydration Status as a Predictor of High-altitude Mountaineering PerformanceEric Ladd, Katherine M Shea, Patrick Bagley, et al.
Journal of Clinical Pharmacology|October 15, 2013
Steady-state pharmacokinetics and pharmacodynamics of meropenem in morbidly obese patients hospitalized in an intensive care unitS Christian Cheatham, Megan R Fleming, Daniel P Healy, et al.
Journal of Pharmacy Practice|August 30, 2017
Significant Publications on Infectious Diseases Pharmacotherapy in 2016Gary Fong, Erik W Skoglund, Kady Phe, et al.
Antimicrobial Agents and Chemotherapy|March 29, 2017
Effect of a Health Care System Respiratory Fluoroquinolone Restriction Program To Alter Utilization and Impact Rates of Clostridium difficile InfectionKatherine M Shea, Athena L V Hobbs, Theresa C Jaso, et al.
Pageof 4